Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 1,907,413 shares were repurchased during the...
-
Louvain-la-Neuve, Belgique, le 27 janvier 2026 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de...
-
Louvain-La-Neuve, Belgium, January 27, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy...
-
Press Release - Inside Information La Hulpe, Belgium –26 January 2026, 7:00 a.m. CET – INSIDE INFORMATION - Banqup Group SA (Euronext: BANQ) (Banqup, Company), a leading provider of integrated...
-
Transparantieverklaring van BlackRock, Inc. In overeenstemming met artikel 14, § 1 van de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen, werd Umicore onlangs op de...
-
Déclaration de transparence par BlackRock, Inc. Conformément à l'article 14, § 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Umicore a récemment été notifiée par...
-
Transparency notification by BlackRock, Inc. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by BlackRock, Inc. that it...
-
Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst Periode van 15 januari 2026 tot 21 januari 2026 Inkoopprogramma van Eigen AandelenOp 21 november 2025, kondigde...
-
Update on the Share Buyback Program and the Liquidity Agreement Period from 15 January 2026 to 21 January 2026 Share Buyback ProgramOn 21 November 2025, Bekaert announced the start of the next...
-
EINDHOVEN, the Netherlands, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to...